Jared Lunceford

Person

Washington, UT, US

People

Patents Grantslast 30 patents

Information Patent Grant
System and methods for deriving gene signature biomarkers of respon...
- Patent number 11,377,693
- Issue date Jul 5, 2022
- Merck Sharp & Dohme LLC
- Mark D. Ayers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Blood-based biomarkers of tumor sensitivity to PD-1 antagonists
- Patent number 11,326,211
- Issue date May 10, 2022
- Merck Sharp & Dohme Corp.
- Mark Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
BIOMARKERS FOR PREDICTING ELIGIBILITY FOR AN ANTI-ILT4 AND ANTI-PD-...
- Publication number 20250044295
- Publication date Feb 6, 2025
- Merck Sharp & Dohme LLC
- Rachel Allison Altura
- G01 - MEASURING TESTING
Information Patent Application
ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RES...
- Publication number 20220380854
- Publication date Dec 1, 2022
- MERCK SHARP & DOHME CORP.
- Mark D. Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTS
- Publication number 20220112564
- Publication date Apr 14, 2022
- MERCK SHARP & DOHME CORP.
- Andrey Loboda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPON...
- Publication number 20180327848
- Publication date Nov 15, 2018
- MERCK SHARP & DOHME CORP.
- Mark D. Ayers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BLOOD-BASED BIOMARKERS OF TUMOR SENSITIVITY TO PD-1 ANTAGONISTS
- Publication number 20180148790
- Publication date May 31, 2018
- MERCK SHARP & DOHME CORP.
- Mark Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PD-L1 GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS
- Publication number 20160312297
- Publication date Oct 27, 2016
- MERCK SHARP & DOHME CORP.
- Mark Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS
- Publication number 20160312295
- Publication date Oct 27, 2016
- MERCK SHARP & DOHME CORP.
- Mark Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAG...
- Publication number 20160304969
- Publication date Oct 20, 2016
- MERCK SHARP & DOHME CORP.
- Mark Ayers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Jared Lunceford

Person

Patents Grantslast 30 patents

System and methods for deriving gene signature biomarkers of respon...

Blood-based biomarkers of tumor sensitivity to PD-1 antagonists

Patents Applicationslast 30 patents

BIOMARKERS FOR PREDICTING ELIGIBILITY FOR AN ANTI-ILT4 AND ANTI-PD-...

ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RES...

GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

SYSTEM AND METHODS FOR DERIVING GENE SIGNATURE BIOMARKERS OF RESPON...

BLOOD-BASED BIOMARKERS OF TUMOR SENSITIVITY TO PD-1 ANTAGONISTS

PD-L1 GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAG...